| GNFT Stock | | | EUR 3.91 0.02 0.51% |
COO
Dean Hum is COO, Chief Scientific Officer, Member of the Management Board of Genfit since 2015.
| Age | 61 |
| Tenure | 9 years |
| Phone | (33) 3 20 16 40 01 |
| Web | www.genfit.com |
Genfit Management Efficiency
The company has return on total asset
(ROA) of
0.1532 % which means that it generated a profit of $0.1532 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.6745 %, meaning that it generated $0.6745 on every $100 dollars invested by stockholders. Genfit's management efficiency ratios could be used to measure how well Genfit manages its routine affairs as well as how well it operates its assets and liabilities.
Genfit has accumulated 72.05
M in total debt with debt to equity ratio
(D/E) of 809.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Genfit has a current ratio of 5.45, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Genfit until it has trouble settling it off, either with new capital or with free cash flow. So, Genfit's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Genfit sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Genfit to invest in growth at high rates of return. When we think about Genfit's use of debt, we should always consider it together with cash and equity.
Genfit SA, a biopharmaceutical company, develops therapeutic and diagnostic solutions for metabolic, inflammatory, and autoimmune or fibrotic diseases affecting primarily the liver and gastro-enterology. Genfit SA was founded in 1999 and is headquartered in Loos, France. GENFIT operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 148 people. Genfit (GNFT) is traded on Euronext Paris in France and employs 134 people.
Management Performance
Genfit Leadership Team
Elected by the shareholders, the Genfit's board of directors comprises two types of representatives: Genfit inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genfit. The board's role is to monitor Genfit's management team and ensure that shareholders' interests are well served. Genfit's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genfit's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stefanie Magner, Chief Affairs | |
| Pascal Caisey, Chief Officer | |
| Dean Hum, COO, Chief Scientific Officer, Member of the Management Board | |
| Thomas Baetz, Chief Officer | |
| Pr Staels, CoFounder Board | |
| JeanChristophe Marcoux, Chief Officer | |
| Pascal Prigent, Chief Officer | |
| Laurent Lannoo, Corp Affairs | |
| Emilie Desodt, VicePres HR | |
| JeanFrancois Mouney, Chairman of the Management Board, CEO | |
Genfit Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genfit a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Information and Resources on Investing in Genfit Stock
When determining whether Genfit is a good investment, qualitative aspects like company
management, corporate governance, and ethical practices play a significant role. A
comparison with peer companies also provides context and helps to understand if Genfit Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Genfit Stock.
Highlighted below are key reports to facilitate an investment decision about Genfit Stock: Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genfit. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For information on how to trade Genfit Stock refer to our
How to Trade Genfit Stock guide.
You can also try the
Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Please note, there is a significant difference between Genfit's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genfit is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genfit's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.